Whitefort Capital Management, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Whitefort Capital Management, LP disclosed 18 US equity positions worth $219.6m in its Q3 2024 13F filing. The largest position was ABUS at 22.6% of the reported book, followed by 0C3 and ROIV.
What did Whitefort Capital Management, LP own in Q3 2024? Top 18 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 22.6% | $49.5m | 12,867,967 | – | |
| 2 | 0C3 ENDEAVOR GROUP HLDGS INC | 13.0% | $28.6m | 1,000,000 | – | ||
| 3 | ROIV ROIVANT SCIENCES LTD | Healthcare | 12.6% | $27.6m | 2,391,000 | – | |
| 4 | JOYY JOYY INC | Communication Services | 9.3% | $20.5m | 565,878 | – | |
| 5 | GNW GENWORTH FINL INC | Financial Services | 9.3% | $20.5m | 2,986,960 | – | |
| 6 | LQDA LIQUIDIA CORPORATION | Healthcare | 7.8% | $17.0m | 1,702,025 | – | |
| 7 | CORZ CORE SCIENTIFIC INC NEW | Technology | 6.2% | $13.6m | 1,147,500 | – | |
| 8 | GLOBAL SHIP LEASE INC NEW | 4.5% | $9.8m | 366,771 | – | ||
| 9 | NN NEXTNAV INC | 4.3% | $9.4m | 1,252,831 | – | ||
| 10 | ESPERION THERAPEUTICS INC NE | 3.5% | $7.6m | 8,000,000 | – | ||
| 11 | SABRE GLBL INC | 2.3% | $5.0m | 5,000,000 | – | ||
| 12 | INNOVATE CORP | 1.9% | $4.1m | 12,218,000 | – | ||
| 13 | MAIDEN HOLDINGS LTD | 1.7% | $3.6m | 2,048,163 | – | ||
| 14 | NEXTNAV INC | 0.6% | $1.4m | 482,951 | – | ||
| 15 | VATE INNOVATE CORP | 0.5% | $1.2m | 320,131 | – | ||
| 16 | OPK OPKO HEALTH INC | Healthcare | 0.1% | $200.4k | 134,490 | – | |
| 17 | TRIB TRINITY BIOTECH PLC | 0.0% | $90.1k | 81,902 | – | ||
| 18 | ALTENERGY ACQUISITION CORP | 0.0% | $2.1k | 186,315 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.